SEC Form 4 · accession 0001209191-15-038058
CUMBERLAND PHARMACEUTICALS INC · CPIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan Griggs
Director
Period of report
Apr 28, 2015
Accepted (ET)
May 1, 2015 · 5:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001087294
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Apr 28, 2015 | M | 700 | $6.69 | A | 6,645 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options | $6.69 | Apr 28, 2015 | M | 700 | D | Jun 1, 2010 | Jun 1, 2015 | Common stock | 700 | 0 | D |
Explanation of responses
- F1Exercise of stock options awarded under the issuers Directors' Incentive Plan. These stock options had an expiration date of June 1, 2015.